United Kingdom· GB-APID-45529811000001108
Voranigo 10mg tablets
A vorasidenib product containing vorasidenib, registered in United Kingdom by Servier Laboratories Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Vorasidenib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01XM04 (vorasidenib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Vorasidenib · ATC L01XM04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Vorasidenib
- Manufacturer
- Servier Laboratories Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XM04
- ATC class
- Vorasidenib
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin03664898124582
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vorasidenib in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaVORANIGOSERVIER CANADA INC
- United StatesVORANIGOServier Pharmaceuticals LLC
- SwitzerlandVoranigo 10 mg, comprimés pelliculésServier (Suisse) SA
- SpainVORANIGO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULALes Laboratoires Servier
- FranceVORANIGO 10 mg, comprimé pelliculéLES LABORATOIRES SERVIER
- NorwayVoranigoLes Laboratoires Servier
- PolandVoranigoLes Laboratoires Servier
- SwedenVoranigo 10 mg Filmdragerad tablettLes Laboratoires Servier
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Voranigo
- Liechtenstein · Voranigo
- Norway · Voranigo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/385f4e20-5963-4a9b-9e82-204dbc222416 GET /v1/drugs/385f4e20-5963-4a9b-9e82-204dbc222416?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45529811000001108",
"desc": "Voranigo 10mg tablets (Servier Laboratories Ltd)",
"form": "Oral tablet",
"vpid": "45531811000001105",
"source": "dmd",
"vtm_id": "45528811000001101",
"strength": "10 mg",
"substance": "Vorasidenib",
"ingredient": "Vorasidenib hemicitric acid hemihydrate",
"supplier_code": "2087101000001102"
}See everything about vorasidenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.